At Zippin Bio, we are pioneers in the field of oligonucleotide (ON) therapeutics, specializing in the treatment of central nervous system (CNS) disorders. Our focus is targeting mRNA with short nucleotide sequences to modulate gene expression and combat genetic diseases. Recognizing the challenges posed by the blood-brain barrier (BBB) in hindering ON clinical benefits, we have embarked on a groundbreaking mission to revolutionize CNS disease treatment. Our innovative approach involves the development of our proprietary nanocarriers, known as ZippinCarriers™, designed to traverse the BBB through receptor-mediated pathways. This strategic alliance aims to enhance ON transport across the BBB, promising unprecedented efficacy and ushering in a new era of gene therapies for CNS diseases.